Shares of InMode Ltd. (NASDAQ:INMD) gained about 2.5% in premarket trading on Monday after the company confirmed it is ...

InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today ...

"The big question is whether InMode will remain in Israel," says company founder and CEO Moshe Mizrahy, talking to "Globes".

The announcement comes amid market speculation, including reports about a non-binding proposal from Steel Partners Holdings L.P. to acquire 51% of InMode’s outstanding shares, as well as recent ...

Steel Partners proposes a $18 per share offer for a majority stake in InMode, citing weak returns, excess cash, and repeated ...

The offer represents a 29% premium over InMode's closing share price last Friday, before speculation around a potential ...

The company went public in 2019 at a post-money valuation of $480 million, according to the report. ・InMode has been facing ...

*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

Good day, and welcome to the InMode fourth quarter and full year 2024 earnings results conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...